"We are positioning Barbados as the anchor of regional health security, actively producing what is needed, when it is needed."
Barbados Pharmaceutical Inc. is building the gateway that connects Caribbean demand with global pharmaceutical expertise.
How We Work
BPI is focused on four strategic priorities. Each one a deliberate step toward a Caribbean that manufactures, distributes, and regulates its own medicines.
Attract & Facilitate Investment
Giving global capital a clear pathway into the Caribbean pharmaceutical market.
Build & Incubate Capacity
Moving strategic projects from concept to execution.
Strengthen Regional Supply Chains
Building the trade corridors and distribution infrastructure the Caribbean depends on.
Build the Ecosystem Foundations
Developing the regulatory, workforce, and research foundations for a permanent sector.
How Health Gets Here
BPI works across six sectors to build the systems, routes, and infrastructure that determine whether essential medicines reach the Caribbean reliably and on time.
1. Market Access & Trade Development
Opening pharmaceutical trade routes across CARICOM, Latin America, Africa, and the Global South.
2. Workforce & Talent Development
Building the skilled workforce Caribbean pharmaceutical production depends on.
3. Research & Development
Establishing Barbados as a credible site for pharmaceutical research and technology transfer.
4. Innovation & Technology
Creating the conditions for pharmaceutical innovation to take root and scale.
5. Regulatory Development & Policy
Building the regulatory framework that gives investors and manufacturers confidence to commit.
6. Investment & Financing
Connecting viable projects to the right capital at the right stage.
1. Market Access & Trade Development
Opening pharmaceutical trade routes across CARICOM, Latin America, Africa, and the Global South.
2. Workforce & Talent Development
Building the skilled workforce Caribbean pharmaceutical production depends on.
3. Research & Development
Establishing Barbados as a credible site for pharmaceutical research and technology transfer.
4. Innovation & Technology
Creating the conditions for pharmaceutical innovation to take root and scale.
5. Regulatory Development & Policy
Building the regulatory framework that gives investors and manufacturers confidence to commit.
6. Investment & Financing
Connecting viable projects to the right capital at the right stage.
"Perhaps the biggest game changer since we have come to office is addressing the issue of pharmaceutical equity and creating a platform for jobs, investment and earnings for a pharmaceutical industry in Barbados for the first time."
Rt. Hon. Mia Amor Mottley, Prime Minister of Barbados
BPI is the institution built to deliver on that mandate, reducing pharmaceutical import dependency and building health sovereignty across the Caribbean.
Initiatives
The AMA Project: The First Africa-Caribbean Pharmaceutical Trade Corridor
To develop a state-of-the-art intravenous (IV) fluids manufacturing facility in a proposed joint venture between BPI & AMA Medical Manufacturing.
BPI x Nigeria PVAC
Spanning manufacturing, clinical trials, market access, and human capital.
EU PharmaNext
A Belgium-based Investment Promotion Office bringing European pharmaceutical capital into the Caribbean.
PAHO Regional Supply Hub
A centralized redistribution hub in Barbados delivering essential health products across 40+ countries faster and with 82% fewer shipments.
Latest from BPI
Barbados Pharmaceutical Inc. Meets WHO and WTO Directors General in Geneva
A small island. A big agenda. Barbados Pharmaceutical Inc. held high level meetings in Geneva with Dr. Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, and Dr. Ngozi Okonjo-Iweala, Director General of the World Trade Organization. These were not courtesy meetings. BPI came with a case and the world's top multilateral leaders heard it.
The Caribbean Is Getting Its First IV Fluids Manufacturing Facility — and It's Being Built in Barbados
The Caribbean imports almost every IV fluid it uses. That changes with the construction of a $31.3 million pharmaceutical manufacturing facility at the Grantley Adams Industrial Estate. A joint venture between Barbados Pharmaceutical Inc. and Nigeria's AMA Medical Manufacturing, with capacity for 12 million units a year. The first of its kind in the region.
Barbados and Nigeria Sign Landmark Pharmaceutical MOU
Barbados Pharmaceutical Inc. and Nigeria's Presidential Initiative for Unlocking the Healthcare Value Chain have signed a Memorandum of Understanding. The first pharmaceutical manufacturing partnership of its kind between Africa and the Caribbean.